申请人:Ciba-Geigy Corporation
公开号:US04677129A1
公开(公告)日:1987-06-30
1-phenyl-3-azabicyclo[3.1.1]-heptane-2,4-diones of the formula ##STR1## in which R.sub.1 represents hydrogen or a saturated or unsaturated, aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, aromatic or aromatic-aliphatic hydrocarbon radical having up to and including 18, preferably up to and including 12, carbon atoms, R.sub.2 represents hydrogen, lower alkyl, sulpho or acyl, R.sub.3 represents hydrogen or lower alkyl and R.sub.4 represents hydrogen, lower alkyl, phenyl or phenyl substituted by --N(R.sub.2)(R.sub.3), and salts of these compounds, have valuable pharmacological properties, are effective as aromatase inhibitors and can therefore be used for the treatment of hormone-dependent diseases, especially mammary carcinoma.
公式为 ##STR1## 的1-苯基-3-氮杂双环[3.1.1]庚烷-2,4-二酮中,其中R.sub.1代表氢或饱和或不饱和的脂肪族,环状脂肪族,环状脂肪族-脂肪族,芳香族或芳香族-脂肪族碳氢基团,碳原子数最多包括18个,优选包括12个及以下;R.sub.2代表氢,低级烷基,磺酰基或酰基;R.sub.3代表氢或低级烷基;R.sub.4代表氢,低级烷基,苯基或被--N(R.sub.2)(R.sub.3)取代的苯基,以及这些化合物的盐,具有有价值的药理学特性,作为芳香族酶抑制剂具有有效性,因此可用于治疗激素依赖性疾病,特别是乳腺癌。